BioCorRx (BICX) Enterprise Value Growth (3y) (2013 - 2026)
BioCorRx (BICX) Enterprise Value Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.71% |
| Mar 31, 2026 | -5.30% |
| Dec 31, 2025 | -31.69% |
| Sep 30, 2025 | 63.01% |
| Jun 30, 2025 | -29.32% |
| Mar 31, 2025 | 6.70% |
| Dec 31, 2024 | -16.60% |
| Sep 30, 2024 | 41.60% |
| Jun 30, 2024 | 42.67% |
| Mar 31, 2024 | 51.54% |
| Dec 31, 2023 | 35.03% |
| Sep 30, 2023 | 35.26% |
| Jun 30, 2023 | 40.74% |
| Mar 31, 2023 | 56.44% |
| Dec 31, 2022 | 58.57% |
| Sep 30, 2022 | 63.01% |
| Jun 30, 2022 | 63.81% |
| Mar 31, 2022 | -53.71% |
| Dec 31, 2021 | 16.69% |
| Sep 30, 2021 | -51.37% |